Therapy News and Research

RSS

Researchers reverse Alzheimer's symptoms in flies by restoring epigenetic balance

Researchers from Drexel University reversed symptoms of Alzheimer's disease in fruit flies by restoring the balance between two epigenetic enzymes that regulate gene expression, a study shows.

15 May 2018

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Multiple myeloma is the second most common type of blood cancer in the United States, impacting more than 25,000 people each year and disproportionatly affecting African-American men.

15 May 2018

Researchers discover unique mechanism that regulates tumor growth in lung cancer

Lung cancer is the third most common type of cancer in Germany and the disease affects both men and women. However, immunotherapies are successful in only 20 percent of cases.

14 May 2018

UTA bioengineering professor successfully patents new cancer trap

The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer.

14 May 2018

Study uncovers promising new line of attack against aggressive prostate cancer

UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Analysis of hundreds of human prostate tumors revealed that the most aggressive cancers depend on a built-in cellular stress response to put a brake on their own hot-wired physiology.

14 May 2018

Disease tolerance is the key to treating TB, say experts

A new study from McGill University suggests it is the body’s ability to “tolerate” rather than “resist” TB infection that stops symptoms of the disease developing.

14 May 2018

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.

14 May 2018

LogicBio team to present data on preclinical effectiveness of GeneRide platform

LogicBio Therapeutics, Inc., a genetic medicine company founded to develop safe medicines with lasting therapeutic benefit for children with life-threatening diseases, today announced it will be presenting data on the company's technology and robust preclinical pipeline at the annual meeting of the American Society of Gene & Cell Therapy at the Hilton Chicago, from May 16-19, 2018.

14 May 2018

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.

14 May 2018

Study gives insight into how signals enter cancer cells and drive aggressive growth

The outside of a cancer cell is bombarded by signals. They come from the immune system, supporting tissues and other structures. But how do those signals impact cancer?

14 May 2018

UCLA researchers identify receptor that plays key role in repairing damage caused by heart conditions

Studies have shown that a simple treatment called lipid emulsion therapy - fatty acids administered intravenously - can heal damage to the heart after a heart attack or cardiac arrest. But researchers haven't understood exactly how the treatment works or whether there are more effective ways to repair the heart.

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Pulmonary vein stenosis (PVS) is a rare disease in which abnormal cells build up inside the veins responsible for carrying oxygen-rich blood from the lungs to the heart. It restricts blood flow through these vessels, eventually sealing them off entirely if left untreated.

11 May 2018

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

President Donald Trump didn't mention Novartis or other drugmakers by name last year when he said the industry is "getting away with murder."

11 May 2018

Chemoradiotherapy could be safely avoided in many rectal cancer patients

It’s unclear whether all patients with advanced rectal cancer need chemoradiotherapy, or whether some can forego the treatment and therefore be spared its side effects.

11 May 2018

CRISPR-based treatment can restore retinal function in mice with eye disease

Researchers from Columbia University have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease, retinitis pigmentosa.

11 May 2018

UAB expert highlights need to do more trials in the epidemic center of disease

Frances Lund, Ph.D., the Charles H. McCauley Chair of Microbiology at the University of Alabama at Birmingham, spoke about chronic inflammatory disease and the striking correlation between location and disease incidence at the recent Fourth International Vatican Conference, "Unite to Cure."

11 May 2018

Therapy News and Research

Researchers reverse Alzheimer's symptoms in flies by restoring epigenetic balance

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Researchers discover unique mechanism that regulates tumor growth in lung cancer

UTA bioengineering professor successfully patents new cancer trap

Study uncovers promising new line of attack against aggressive prostate cancer

Disease tolerance is the key to treating TB, say experts

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

LogicBio team to present data on preclinical effectiveness of GeneRide platform

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

Study gives insight into how signals enter cancer cells and drive aggressive growth

UCLA researchers identify receptor that plays key role in repairing damage caused by heart conditions

FDA approves new drug to treat MS in pediatric patients

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

Chemoradiotherapy could be safely avoided in many rectal cancer patients

CRISPR-based treatment can restore retinal function in mice with eye disease

UAB expert highlights need to do more trials in the epidemic center of disease

New survey shows 80% of oncologists have discussed medical marijuana use with patients

Study explains anti-obesity effects of melatonin

Good bacteria is bad news for atherosclerosis

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News